Epidemic of lung cancer in patients with hiv infection

Chest

Volumn 143, Issue 2, 2013, Pages 305-314

  Winston, Tiffany A ^a   Man, S F Paul ^a,b   Hull, Mark ^a,b   Montaner, Julio S ^b   Sin, Don D ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; GENDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; INTRAVENOUS DRUG ADMINISTRATION; KAPOSI SARCOMA; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; ONSET AGE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; SMOKING; SOLID TUMOR; SURVIVAL;

EID: 84874068719     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1699     Document Type: Note

References (54)

1. Biggar RJ, Engels EA, Ly S, et al. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr. 2005; 39 (3): 293-299.
2. Alshafie MT, Donaldson B, Oluwole SF. Human immunodefi- ciency virus and lung cancer. Br J Surg. 1997; 84(8): 1068-1071.
3. Engels EA, Pfeiffer RM, Goedert JJ, et al; for the HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS. 2006; 20 (12): 1645-1654.
4. Long JL, Engels EA, Moore RD, Gebo KA. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008; 22 (4): 489-496.
5. Patel P, Hanson DL, Sullivan PS, et al; Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008; 148 (10): 728-736.
6. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009; 27 (6): 884-890.
7. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011; 103 (9): 753-762.
8. Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001; 285 (13): 1736-1745.
9. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009; 52 (5): 611-622.
10. Karp J, Profeta G, Marantz PR, Karpel JP. Lung cancer in patients with immunodeficiency syndrome. Chest. 1993; 103 (2): 410-413.
11. Sridhar KS, Flores MR, Raub WA Jr, Saldana M. Lung cancer in patients with human immunodeficiency virus infection compared with historic control subjects. Chest. 1992; 102 (6): 1704-1708.
12. Vyzula R, Remick SC. Lung cancer in patients with HIV-infection. Lung Cancer. 1996; 15 (3): 325-339.
13. Parker MS, Leveno DM, Campbell TJ, Worrell JA, Carozza SE. AIDS-related bronchogenic carcinoma: fact or fiction? Chest. 1998; 113 (1): 154-161.
14. Tirelli U, Spina M, Sandri S, et al; The Italian Cooperative Group on AIDS and Tumors. Lung carcinoma in 36 patients with human immunodeficiency virus infection. Cancer. 2000; 88 (3): 563-569.
15. Bower M, Powles T, Nelson M, et al. HIV-related lung cancer in the era of highly active antiretroviral therapy. AIDS. 2003; 17 (3): 371-375.
16. Spano JP, Massiani MA, Bentata M, et al. Lung cancer in patients with HIV infection and review of the literature. Med Oncol. 2004; 21 (2): 109-115.
17. Powles T, Thirwell C, Newsom-Davis T, et al. Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART? Br J Cancer. 2003; 89 (3): 457-459.
18. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol. 2006; 24(9): 1383-1388.
19. Hakimian R, Fang H, Thomas L, Edelman MJ. Lung cancer in HIV-infected patients in the era of highly active antiretroviral therapy. J Thorac Oncol. 2007; 2 (4): 268-272.
20. Brock MV, Hooker CM, Engels EA, et al. Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care. J Acquir Immune Defic Syndr. 2006; 43 (1): 47-55.
21. Lavolé A, Chouaïd C, Baudrin L, et al. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer. Lung Cancer. 2009; 65 (3): 345-350.
22. Bertolaccini L, Lybéris P, Soncinim S, Di Perri G, Manno E. Clinical characteristic lung cancer in HIV-infected patients. Cancer Ther. 2008; 6: 903-906.
23. Pakkala S, Chen Z, Rimland D, et al. Human immunodefi- ciency virus-associated lung cancer in the era of highly active antiretroviral therapy. Cancer. 2012; 118 (1): 164-172.
24. D'Jaen GA, Pantanowitz L, Bower M, et al. Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. Clin Lung Cancer. 2010; 11 (6): 396-404.
25. Engsig FN, Kronborg G, Larsen CS, et al. Lung cancer in HIV patients and their parents: a Danish cohort study. BMC Cancer. 2011; 11: 272.
26. Ruiz M. Lung cancer in HIV-infected patients: the experience of an urban clinic. J Int Assoc Physicians AIDS Care (Chic). 2010; 9 (4): 214-217.
27. Clifford GM, Lise M, Franceschi S, et al; Swiss HIV Cohort Study. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer. 2012; 106 (3): 447-452.
28. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D; Clinical Epidemiology Group of the FHDHANRS CO4 cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009; 10 (12): 1152-1159.
29. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370 (9581): 59-67.
30. Cooksley CD, Hwang LY, Waller DK, Ford CE. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS. 1999; 10 (12): 795-802.
31. Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol. 2001; 154 (6): 544-556.
32. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003; 21 (18): 3447-3453.
33. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007; 165 (10): 1143-1153.
34. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008; 123 (1): 187-194.
35. Clifford GM, Polesel J, Rickenbach M, et al; Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005; 97 (6): 425-432.
36. Dal Maso L, Polesel J, Serraino D, et al; Cancer and AIDS Registries Linkage (CARL) Study. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009; 100 (5): 840-847.
37. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr. 2009; 52 (2): 203-208.
38. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009; 23 (17): 2337-2345.
39. Shiels MS, Pfeiffer RM, Engels EA. Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med. 2010; 153 (7): 452-460.
40. Chaturvedi AK, Pfeiffer RM, Chang L, Goedert JJ, Biggar RJ, Engels EA. Elevated risk of lung cancer among people with AIDS. AIDS. 2007; 21 (2): 207-213.
41. Kirk GD, Merlo C, O'Driscoll P, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007; 45 (1): 103-110.
42. Shiels MS, Cole SR, Mehta SH, Kirk GD. Lung cancer incidence and mortality among HIV-infected and HIV-uninfected injection drug users. J Acquir Immune Defic Syndr. 2010; 55 (4): 510-515.
43. Wistuba II, Behrens C, Milchgrub S, et al. Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA. 1998; 279(19): 1554-1559.
44. el-Solh A, Kumar NM, Nair MP, Schwartz SA, Lwebuga-Mukasa JS. An RGD containing peptide from HIV-1 Tat-(65-80) modulates protooncogene expression in human bronchoalveolar carcinoma cell line, A549. Immunol Invest. 1997; 26 (3): 351-370.
45. Baker ME, Yan L, Pear MR. Three-dimensional model of human TIP30, a coactivator for HIV-1 Tat-activated transcription, and CC3, a protein associated with metastasis suppression. Cell Mol Life Sci. 2000; 57 (5): 851-858.
46. Tong X, Li K, Luo Z, et al. Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol. 2009; 174 (5): 1931-1939.
47. Engels EA. Human immunodeficiency virus infection, aging, and cancer. J Clin Epidemiol. 2001; 54 (suppl 1): S29-S34.
48. Engels EA. Infl ammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther. 2008; 8 (4): 605-615.
49. Shebl FM, Engels EA, Goedert JJ, Chaturvedi AK. Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr. 2010; 55 (3): 375-379.
50. Sogaard OS, Lohse N, Gerstoft J, et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study. Clin Infect Dis. 2008; 47 (10): 1345-1353.
51. Giordano TP, Kramer JR. Does HIV infection independently increase the incidence of lung cancer? Clin Infect Dis. 2005; 40 (3): 490-491.
52. Serraino D, Boschini A, Carrieri P, et al. Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS. 2000; 14 (5): 553-559.
53. Levine AM, Seaberg EC, Hessol NA, et al. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol. 2010; 28 (9): 1514-1519.
54. Sigel K, Wisnivesky J, Gordon K, et al. HIV as an independent risk factor for incident lung cancer. AIDS. 2012; 26 (8): 1017-1025.